• LAST PRICE
    13.3900
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    12.7000/ 1
  • Ask / Lots
    0.0000/ 0
  • Open / Previous Close
    12.1400 / 13.3900
  • Day Range
    Low 12.0700
    High 13.3950
  • 52 Week Range
    Low 11.5600
    High 35.6800
  • Volume
    77,349
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 12.51
TimeVolumeIMGO
09:32 ET33112.14
09:36 ET60012.23
09:59 ET10012.295
10:01 ET10012.35
10:03 ET10012.15
10:06 ET20012.28
10:14 ET10012.28
10:15 ET30012.35
10:24 ET20012.47
10:26 ET10012.47
10:35 ET10012.7
10:37 ET10012.77
10:39 ET10012.85
10:46 ET40012.84
10:50 ET110012.67
10:51 ET10012.75
10:53 ET10012.72
10:57 ET10012.835
11:00 ET40012.72
11:02 ET10012.925
11:04 ET80012.75
11:06 ET10012.865
11:08 ET10012.78
11:09 ET20012.86
11:11 ET20012.87
11:18 ET30012.9
11:20 ET30012.8325
11:26 ET30012.87
11:27 ET20012.81
11:33 ET10012.7
11:36 ET70012.74
11:38 ET430012.66
11:40 ET30012.705
11:42 ET30012.7495
11:44 ET10012.695
11:45 ET60012.76
11:47 ET10012.77
11:49 ET30012.82
11:56 ET10012.84
11:58 ET20012.85
12:00 ET50012.91
12:03 ET70012.9
12:07 ET20012.915
12:09 ET10012.93
12:12 ET30012.87
12:14 ET10012.87
12:16 ET10012.89
12:21 ET20012.95
12:25 ET20013.01
12:27 ET10013.13
12:34 ET30013.17
12:41 ET54713.06
12:43 ET30013.07
12:50 ET10013.13
12:52 ET10013.05
12:54 ET10013.13
12:59 ET14713.11
01:14 ET70013.07
01:15 ET40012.985
01:21 ET40013.02
01:24 ET10013.005
01:35 ET10013.08
01:42 ET20013.115
01:44 ET10013.16
01:46 ET20013.07
01:51 ET10013.13
01:55 ET20013.13
01:57 ET10013.18
02:00 ET10013.14
02:06 ET20013.09
02:13 ET20013.13
02:15 ET20013.13
02:26 ET20013.06
02:27 ET110013.13
02:33 ET20013.1
02:38 ET10013.1
02:42 ET40013.05
02:44 ET50013.07
02:47 ET10013.04
02:51 ET10013.05
02:54 ET124813.045
02:56 ET20013.14
02:58 ET10013.165
03:00 ET40013.175
03:02 ET50013.2
03:05 ET10013.185
03:07 ET60013.157
03:09 ET20013.12
03:12 ET40013.08
03:14 ET30013.129
03:16 ET50013.2
03:18 ET80013.13
03:20 ET10013.15
03:21 ET40013.17
03:23 ET10013.165
03:25 ET30013.22
03:27 ET70013.26
03:30 ET10013.26
03:32 ET80013.31
03:34 ET30013.35
03:36 ET20013.325
03:38 ET20013.34
03:39 ET10013.305
03:43 ET20013.29
03:48 ET20013.35
03:50 ET48013.32
03:52 ET87713.32
03:54 ET30013.34
03:56 ET102013.36
03:57 ET80013.35
03:59 ET180013.39
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesIMGO
Imago BioSciences Inc
422.0M
-8.4x
---
United StatesMRSN
Mersana Therapeutics Inc
431.6M
-1.9x
---
United StatesKOD
Kodiak Sciences Inc
411.5M
-1.3x
---
United StatesRGC
Regencell Bioscience Holdings Ltd
408.4M
-324.8x
---
United StatesTRDA
Entrada Therapeutics Inc
405.9M
0.0x
---
United StatesINO
Inovio Pharmaceuticals Inc
410.0M
-1.1x
---
As of 2022-07-01

Company Information

Imago BioSciences, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing small molecule product candidates that target lysine-specific demethylase 1 (LSD1), an enzyme that plays a central role in the production of blood cells in the bone marrow. It focuses on providing treatment for patients with cancer and bone marrow diseases. The Company’s lead product candidate is bomedemstat, which is developed for the treatment of myeloproliferative neoplasms (MPNs), a chronic cancer of the bone marrow. The Company’s product candidate, bomedemstat, is in Phase II clinical trial for the treatment of essential thrombocythemia (ET). The Company also develops bomedemstat and other LSD1-targeting product candidates for additional indications in areas of unmet medical need. It tests bomedemstat in mouse models of MPNs as a single agent.

Contact Information

Headquarters
2729 Debbie CourtSAN CARLOS, CA, United States 94070-4323
Phone
650-325-5156
Fax
302-655-5049

Executives

Independent Chairman of the Board
Dennis Henner
Chief Executive Officer, Director
Hugh Rienhoff
Chief Financial Officer
Laura Eichorn
Chief Operating and Business Officer
Michael Arenberg
Senior Vice President - Clinical Operations
Jennifer Peppe

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$422.0M
Revenue (TTM)
$0.00
Shares Outstanding
33.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.59
Book Value
$6.40
P/E Ratio
-8.4x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.